Allergy & Immunology

A review examines whether targeting multiple inflammatory pathways could improve severe nasal polyp care.

COVID-19 infection was associated with increased risks of six allergic conditions over 18 months. Findings differed in children and active-duty service members, highlighting a potential burden of allergic disease after infection.

Ultra-low-dose induction helped children with severe peanut or walnut allergies progress to conventional oral immunotherapy.

A multicentre retrospective study found that sinonasal disease rates differed according to induction and maintenance immunosuppression among kidney and liver transplant recipients.

Long-term benzene exposure was associated with increased allergic rhinitis risk in more than 76,000 older adults.

Spatial transcriptomics revealed organised immune niches that may sustain inflammation in atopic dermatitis.

Distinct T cell populations were linked to disease activity and treatment response in children with EoE.

A phase 2 trial found that dupilumab improved lung function, reduced severe respiratory exacerbations and decreased systemic corticosteroid use in patients with asthma and ABPA.